| Literature DB >> 35330198 |
Alin Mihai Vasilescu1, Eugen Târcoveanu1, Cristian Lupascu1, Mihaela Blaj2, Corina Lupascu Ursulescu3, Costel Bradea1.
Abstract
Abdominopelvic actinomycosis is a rare chronic or subacute bacterial infection caused by Actinomyces israelii, a Gram-positive anaerobic bacterium that normally colonizes the digestive and genital tracts, clinically presented as an inflammatory mass or abscess formation.Entities:
Keywords: abdominopelvic actinomycosis; colon cancer; hepatic actinomycosis; inflammatory tumor; pelvic tumor
Year: 2022 PMID: 35330198 PMCID: PMC8954618 DOI: 10.3390/life12030447
Source DB: PubMed Journal: Life (Basel) ISSN: 2075-1729
Figure 1Abdominal ultrasound discovered a heterogeneous abdominal tumor and peritumoral fluid.
Figure 2CT scan—heterogeneous mass involving distal ileum; inflammatory changes of the mesentery were also observed.
Figure 3Transverse colon actinomycosis, intraoperative view and operative specimen on the section.
Figure 4Intraoperatory view—laparoscopic resection of a large omentum mass, with adhesions to the parietal peritoneal serosa.
Figure 5Abdominal actinomycosis. PAS Positive—Actinomyces israelii Colony, X 20.
The main characteristics of the 28 patients with abdominopelvic actinomycosis.
| Age | 43.36 ± 19.14 years (18–64 years) |
| Gender | 9 male/19 female patients |
| Predisposing factors | N (cases) (%) |
| Long-term IUDs | 13/28 (46.4%) |
| Diabetes | 5/28 (17.8%) |
| Foreign bodies | |
| Toothpick | 1/28 (3.5%) |
| Gallstones lost in the peritoneum | 1/28 (3.5%) |
| Stenting of the bile duct | 1/28 (3.5%) |
| Immunosuppression | 3/28 (10.7%) |
| Diverticulitis | 3/28 (10.7%) |
| Oral diseases associated | 5/28 (17.8%) |
| Gastroesophageal reflux associated | 9/28 (32.1%) |
| No predisposing factors | 1/28 (3.5%) |
| Clinical features | N (cases) (%) |
| Distended abdomen with tenderness | 11/28 (39.2%) |
| Tumor palpable | 4/28 (14.2%) |
| Deep organ adhesion | 12/28 (42,3%) |
| Abdominal pain | 18/28 (76,9%) |
| Fever | 17/28 (61,5%) |
| Weight loss | 14/28 (50%) |
| Anemia | 13/28 (46.4%) |
| Leukocytosis | 23/28 (82.14%) |
| The mean duration of symptoms | |
| Chronic or subacute symptoms | 2.8 ± 2.4 month (1–14 months) |
| Emergency | 11.7 ± 9.2 days (7–21 days) |
| Imaging (US, CT) characteristic | N (cases) (%) |
| Intraperitoneal collections | 11/28 (39.2%) |
| A heterogeneous mass involving the colon | 6/28 (21.4%) |
| Omental mass | 3/28 (10.7%) |
| Inflammatory mass involving the ovaries | 6/28 (21.4%) |
| Right liver abscesses | 2/28 (7.1%) |
| Treatment | N (cases) (%) |
| Open approach | 6/28 (21.4%) |
| Right hemicolectomy | 3/6 (50%) |
| Segmental colectomy | 2/6 (33.3%) |
| Drainage of peritoneal abscess | 1/6 (17.6%) |
| Laparoscopic approach | 21/28 (21.4%) |
| Omental laparoscopic resection | 3/21 (14.2%) |
| Right hemicolectomy | 1/21 (4.7%) |
| Bilateral salpingo-oophorectomy | 6/21 (28.5%) |
| Drainage of peritoneal abscess | 11/21 (5.2%) |
| Drainage and biopsy of the liver abscess | 1/21 (4.7%) |
| Radiologic percutaneous approach of the liver abscess | 1/28 (3.5%) |
| Postoperative treatment—intravenous penicillin for 4–6 weeks (12 to 20 million units daily in divided doses every four to six hours) + amoxicillin oral | 6.5 months ± 4.6 months (3 weeks–12 months) |
| Recurrences | 3/28 (10.7%) |
Publications of cases with abdominopelvic actinomycosis.
| Author/Year | Total Cases | Involved Sites | Mean Age | Gender, M/F | Predisposing Factors | Leukocytosis | Presumptive | Final Diagnosis | Treatment |
|---|---|---|---|---|---|---|---|---|---|
| Yegüez JF et al., 2000 [ | 1 | Rectosigmoid and cecum | 49 | F | − | − | Tumor of colon | Histologic | Resection and colostomy + actinomycosis medication |
| Cirafici L et al., 2002 [ | 1 | Left colon | 56 | F | IUD | + | Tumor occlusive of colon | Histologic | Colostomy + actinomycosis medication |
| Chelli D et al., 2008 [ | 5 | Pelvic inflammatory disease | 39.2 | F | IUD | + | Pelvic inflammatory disease | Culture of the microorganisms | Drainage + actinomycosis medication |
| Privitera A et al., 2009 [ | 1 | Left colon | 67 | M | + | Abscessed tumors of the sigmoid colon | Histologic | Hartmann’s procedure + actinomycosis medication | |
| Lim KT et al., 2010 [ | 1 | Abdominal wall mass that extended from the dome of the bladder | 26 | M | − | + | Urachal tumor | Histologic | Partial cystectomy with abdominal wall mass excision + actinomycosis medication |
| Marret H et al., 2010 [ | 11 | Ovary, colon, pelvic inflammatory disease | F | IUD | + | Pelvic inflammatory disease, ovarian cancer, bowel obstruction, acute peritonitis | Culture of the microorganisms, histologic | Total abdominal hysterectomy; salphingo-oophorectomy + actinomycosis medication | |
| Sung HY et al., 2011 [ | 23 | Appendix (n = 5), ovarian mass (n = 5), abdominal wall mass (n = 4), colonic mass (n = 4), small bowel mass (n = 2), uterus mass (n = 2), and liver | 47.8 | 5 M/18 F | IUD, total abdominal hysterectomy, Caesarean section, a fish bone-induced rectal perforation polypectomy-induced microperforation, peritoneal dialysis, cholecystectomy with T-tube drainage | + | Acute appendicitis (n = 10), pelvic inflammatory disease (n = 8), and acute tubo-ovarian abscess (n = 4), ovarian cancer, or colon cancer | Histologic | Right hemicolectomy; left hemicolectomy; total abdominal hysterectomy; salphingo-oophorectomy + actinomycosis medication |
| Jabi R et al., 2020 [ | 1 | Left colon | 48 | M | − | + | Tumor of the left colon | Histologic | Left segmental colectomy with latero-lateral mechanical anastomosis + actinomycosis medication |
| Asiri BI et al., 2020 [ | 1 | Appendix | 38 | M | − | + | Acute appendicitis and cecum tumor | Histologic | Appendectomy and laparoscope-assisted ileocaecal resection with ileocolic anastomosis + actinomycosis medication |
| Kim S et al., 2020 [ | 1 | Peritoneal and pelvic masses | 47 | F | IUD | − | Peritoneal carcinomatosis | Histologic diagnosis of surgical specimen | Peritoneal biopsy + actinomycosis medication |
| Pamathy G et al., 2021 [ | 1 | Transverse and descending colon | 40 | F | IUD | + | Transverse and descending colon malignancy | Histologic diagnosis of surgical specimen | Left hemicolectomy |
| Clarrett D et al., 2021 [ | 1 | Transverse colon, abdominal wall | 66 | M | − | − | Transverse colon malignancy | Histologic diagnosis of surgical specimen | Surgical resection of the right upper abdominal wall mass en bloc with right hemicolectomy |
| Tarzi M et al., 2021 [ | 1 | Abdominal wall | 59 | M | Type 2 diabetes | − | Abdominal wall tumor | Histologic diagnosis of surgical specimen | Surgical excisional biopsy |